Blocking critical signaling pathways in HCC, such as STAT3/VEGF/HIF-1α.Prevent tumor growth and angiogenesis.Cell cycle arrest, especially in the S phase. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.